BlackRock Group’s Clovis Oncology, Inc. CLVS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $930K | Sell |
20,918
-5,342
| -20% | -$238K | ﹤0.01% | 2150 |
|
2016
Q3 | $947K | Buy |
26,260
+8,335
| +46% | +$301K | ﹤0.01% | 2048 |
|
2016
Q2 | $246K | Sell |
17,925
-2,825
| -14% | -$38.8K | ﹤0.01% | 2495 |
|
2016
Q1 | $398K | Buy |
20,750
+3,895
| +23% | +$74.7K | ﹤0.01% | 2312 |
|
2015
Q4 | $589K | Buy |
16,855
+789
| +5% | +$27.6K | ﹤0.01% | 2119 |
|
2015
Q3 | $1.48M | Buy |
16,066
+4,887
| +44% | +$449K | ﹤0.01% | 1651 |
|
2015
Q2 | $982K | Buy |
11,179
+5,307
| +90% | +$466K | ﹤0.01% | 1962 |
|
2015
Q1 | $435K | Buy |
5,872
+1,063
| +22% | +$78.7K | ﹤0.01% | 2239 |
|
2014
Q4 | $269K | Buy |
4,809
+385
| +9% | +$21.5K | ﹤0.01% | 2423 |
|
2014
Q3 | $201K | Sell |
4,424
-110
| -2% | -$5K | ﹤0.01% | 2435 |
|
2014
Q2 | $188K | Sell |
4,534
-4,874
| -52% | -$202K | ﹤0.01% | 2448 |
|
2014
Q1 | $652K | Buy |
9,408
+2,216
| +31% | +$154K | ﹤0.01% | 2127 |
|
2013
Q4 | $433K | Sell |
7,192
-23,798
| -77% | -$1.43M | ﹤0.01% | 2235 |
|
2013
Q3 | $1.88M | Sell |
30,990
-29,589
| -49% | -$1.8M | ﹤0.01% | 1491 |
|
2013
Q2 | $4.06M | Buy |
+60,579
| New | +$4.06M | ﹤0.01% | 1028 |
|